Alto, a San Francisco-based digital pharmacy founded in 2015, has raised $592 million across multiple funding rounds, achieving a $1 billion valuation after its $200 million Series E round in January 2022, led by SoftBank Vision Fund. Other key investors include Greenoaks, Jackson Square Ventures, and Meritech Capital. Alto’s platform combines expert pharmacist care, prescription management, and same-day delivery to simplify access to and affordability of medications. With over 1,400 employees, the company is reshaping how patients and healthcare providers manage prescriptions digitally.